Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome

NCT00443144 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00443144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00443144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
May 31, 2005
Completion date
May 31, 2007
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

short stature, turner syndrome